Tag: Cardiol Therapeutics Inc.

October 1, 2019

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx(TM)100

Cardiol Therapeutics Inc., announces that it has completed the manufacturing scale-up for commercialization of its CardiolRx™100 CBD formulation.
September 5, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) President & CEO David Elsley will present live at the KCSA Cannabis Investor Conference on...
July 25, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), focused on producing pharmaceutical CBD products and developing innovative therapies for...
June 20, 2019

Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company") is pleased to announce that the Company is planning...
June 10, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...
June 3, 2019

Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD)...
May 30, 2019

Cardiol Therapeutics Commences Trading on the OTCQX

Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...